Jonathan Slonin, Chief Medical Officer at Pacira BioSciences, Inc. (PCRX), sold 3,261 shares at $22.82 ($74K) on 2026-03-17, disclosed to the SEC on 2026-03-19.
Scheduled sale ($74k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | SELL | 2025-01-06 | $16K | — | Filing → |
| PCRX | SELL | 2024-08-02 | $19K | — | Filing → |
| PCRX | SELL | 2024-07-03 | $80K | — | Filing → |